Edition:
United Kingdom

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

55.55USD
21 Sep 2018
Change (% chg)

$-1.63 (-2.85%)
Prev Close
$57.18
Open
$57.86
Day's High
$57.90
Day's Low
$54.40
Volume
528,056
Avg. Vol
193,597
52-wk High
$96.51
52-wk Low
$41.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 25.18 2.071
Mar '18 15.68 -1.252
FY 2017 Dec '17 7.41 -1.745
Sep '17 1.90 -1.898
Jun '17 1.48 -2.401
Mar '17 1.27 -1.699
FY 2016 Dec '16 16.30 -1.205
Sep '16 1.30 -1.072
Jun '16 1.29 -1.044
Mar '16 1.29 -0.954
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 17 28.73 53.00 8.40 17.35
Quarter Ending Dec-18 17 30.74 69.60 12.13 23.42
Year Ending Dec-18 20 103.36 149.60 71.13 99.68
Year Ending Dec-19 20 121.62 186.40 80.70 262.30
Earnings (per share)
Quarter Ending Sep-18 20 -0.90 -0.15 -2.44 -1.54
Quarter Ending Dec-18 20 -1.07 0.08 -2.27 -1.35
Year Ending Dec-18 16 -1.00 0.81 -3.81 -5.01
Year Ending Dec-19 21 -4.13 -1.69 -7.94 -1.34
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 153.83 114.98 5.74
Price to Book (MRQ) 11.96 15.51 5.00
Price to Tangible Book (MRQ) 13.80 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 83.26 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 15.10 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -3.39 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -129.91 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -116.29 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 6.09 5.46 3.03
LT Debt to Equity (MRQ) 0.47 35.27 12.51
Total Debt to Equity (MRQ) 0.60 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -816.79 -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -984.26 -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -973.11 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -962.76 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 95,602 23,229,030 860,305,024
Net Income/Employee (TTM) -920,417 3,144,146 101,198,978
Receivable Turnover (TTM) 6.52 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.06 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.26 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -61.15 1.79 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -63.88 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -8.52 -- --
EPS (TTM) % -104.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spark Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.35 2.68 99 52
13 Week 41.42 34.53 99 66
26 Week 71.05 58.05 99 80
52 Week 44.55 22.52 99 50
YTD 75.23 53.89 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 263
Total Shares Held: 40,244,631
3 Mo. Net Change: 545,689
# New Positions: 35
# Closed Positions: 28
# Increased Positions: 120
# Reduced Positions: 103
# Net Buyers: 17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.